Dermatology drugs

111 results

  • absorica

    (isotretinoin)
    Sun Pharmaceutical Industries, Inc.
    ABSORICA and ABSORICA LD are indicated for treating severe recalcitrant nodular acne in non-pregnant patients aged 12 and older, unresponsive to conventional therapies. A two-month waiting period is recommended before a second course, as acne may continue to improve after initial treatment.

  • accutane

    (ISOTRETINOIN)
    JG Pharma Inc.
    Accutane is indicated for severe recalcitrant nodular acne in patients unresponsive to conventional therapy, including systemic antibiotics. It is contraindicated in pregnant patients due to potential life-threatening birth defects. A single 15 to 20-week treatment course may lead to prolonged remission.

  • aczone

    (dapsone)
    Almirall, LLC
    ACZONE® (dapsone) Gel, 7.5%, is indicated for the topical treatment of acne vulgaris in patients aged 9 years and older.

  • adbry

    (tralokinumab-ldrm)
    LEO Pharma Inc.
    ADBRY is indicated for treating moderate-to-severe atopic dermatitis in adults and pediatric patients aged 12 and older when topical therapies are ineffective or unsuitable. It may be used with or without topical corticosteroids.

  • aklief

    (trifarotene)
    Galderma Laboratories, L.P.
    AKLIEF Cream is a retinoid indicated for the topical treatment of acne vulgaris in patients aged 9 years and older.

  • albuked

    (Albumin (Human))
    KEDRION BIOPHARMA, INC.
    Albuked 5 is indicated for the emergency treatment of hypovolemic shock, burn therapy, cardiopulmonary bypass, acute liver failure, and sequestration of protein-rich fluids. It aids in expanding circulating blood volume and maintaining colloid osmotic pressure in various clinical scenarios.

  • altreno

    (tretinoin)
    Bausch Health US, LLC
    ALTRENO® (tretinoin) lotion, 0.05% is indicated for the topical treatment of acne vulgaris in patients aged 9 years and older.

  • ameluz

    (aminolevulinic acid hydrochloride)
    Biofrontera Inc.
    AMELUZ is indicated for the lesion-directed and field-directed treatment of mild-to-moderate actinic keratoses (AKs) on the face and scalp, used in combination with photodynamic therapy (PDT) utilizing BF-RhodoLED or RhodoLED XL lamps.

  • amjevita

    (adalimumab-atto)
    Amgen Inc
    AMJEVITA is indicated for treating various conditions, including rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis in adults and pediatric patients, depending on the specific condition.

  • amzeeq

    (Minocycline)
    Journey Medical Corporation
    AMZEEQ is indicated for the topical treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris in adults and pediatric patients aged 9 and older. It is not intended for treating infections and should be used to prevent drug-resistant bacteria development.